The lab-made 3D liver model serves as a human relevant platform for analyzing the progressive stages of the liver disease, ...

By reactivating a long-lost gene, researchers were able to lower uric acid levels and stop damaging fat accumulation in human ...

Cellarity, a clinical-stage biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced the publication of a seminal manuscript in ...

As chronic liver disease becomes more widespread, researchers at Science Tokyo have developed a lab-grown organoid that replicates a regenerating ...

The Physicians Committee for Responsible Medicine, a nonprofit that advances human-based science, and InSphero, a global leader in 3D in vitro technology for drug safety and efficacy testing, are ...

As chronic liver disease becomes more widespread, researchers at Science Tokyo have developed a lab-grown organoid that ...

Researchers linked a new PFAS chemical, PFHpA, to worsening liver disease in teens with obesity, raising fresh concerns about hidden toxins.

DILI is one of the most significant safety challenges in developing therapeutics today, as hepatic safety events undetected in preclinical testing can occur in patients leading to clinical trial ...

Dimension Bio, a biotechnology company pioneering regenerative therapeutics, today announced the formation of its inaugural Clinical Advisory Board (CAB) and Scientific Advisory Board (SAB). The ...

Massive SNAP cuts could deprive millions of Americans of food aid, burden states, and increase hunger, health issues, and ...